• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THE SPECTRANETICS CORPORATION SPECTRANETICS TURBO ELITE LASER ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THE SPECTRANETICS CORPORATION SPECTRANETICS TURBO ELITE LASER ATHERECTOMY CATHETER; CATHETER, PERIPHERAL, ATHERECTOMY Back to Search Results
Model Number 423-001
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Occlusion (1984)
Event Date 08/17/2020
Event Type  Injury  
Manufacturer Narrative
Patient information unavailable.
 
Event Description
A peripheral atherectomy procedure commenced to treat a plaque occlusion in the patient's distal left superficial femoral artery (sfa).A stent was reportedly present in patient's sfa region prior to the procedure, and the condition of the lesion within the patient's vasculature was reported to be in poor condition.The physician chose to use a spectranetics turbo elite laser atherectomy catheter to perform the procedure.To start the procedure, the physician used an ipsilateral access.However, the lesion was found to be very tight (severely narrowed) at the proximal sfa region.Attempt was then made to access the lesion from a retrograde approach, entering from the popliteal artery in order to cross the lesion.The physician finally could cross to 1cm from the stent's distal edge, using a knuckle wire technique with 0.035" guide wire.Afterward, using a microcatheter and other interventions, the 0.035" guide wire could cross to popliteal.Then, a 0.014" guide wire was used and the lesion was able to be crossed with use of the turbo elite device two times.Afterward, a drug coated balloon was used, dilated, and completed the procedure with no reported patient harm.However, on 18 august 2020 it was reported that an acute occlusion at the left sfa was confirmed by echocardiogram.Interventions were implemented and the patient experienced a prolonged hospitalization.In an email received on 21 august from the physician, he thought that there was no relationship between the acute occlusion and the turbo elite catheter.Although the turbo elite catheter was present in the area in which an acute occlusion was discovered, this event has been determined to be related to the procedure (the physician stated that the occlusion is a phenomenon that can occur, and it is unlikely that the use of this device was the cause) and to the patient condition (as mentioned before, the patient's lesion was in poor condition).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRANETICS TURBO ELITE LASER ATHERECTOMY CATHETER
Type of Device
CATHETER, PERIPHERAL, ATHERECTOMY
Manufacturer (Section D)
THE SPECTRANETICS CORPORATION
9965 federal drive
colorado springs CO 80921
Manufacturer Contact
barbara creel
9965 federal drive
colorado springs, CO 80921
719447-246
MDR Report Key10484131
MDR Text Key207921975
Report Number1721279-2020-00188
Device Sequence Number1
Product Code MCW
UDI-Device Identifier00813132024772
UDI-Public(01)00813132024772(17)211126(10)FBC19L19A
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
K170059
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,consum
Reporter Occupation Physician
Type of Report Initial
Report Date 01/01/2005,08/19/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/02/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date11/26/2021
Device Model Number423-001
Device Catalogue Number423-001
Device Lot NumberFBC19L19A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received08/19/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/19/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
-
-